alosetron   Click here for help

GtoPdb Ligand ID: 2296

Synonyms: GR68755 | Lotronex®
Approved drug PDB Ligand
alosetron is an approved drug (FDA (2002))
Compound class: Synthetic organic
Comment: Having been withdrawn by the manufacturer in 2000 following reports of severe adverse effects, the FDA approved a supplemental new drug application (2002) which allows remarketing of the drug, but under conditions of restricted use.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 2
Topological polar surface area 53.92
Molecular weight 294.15
XLogP 2.32
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C1N(CCc2c1c1ccccc1n2C)Cc1nc[nH]c1C
Isomeric SMILES O=C1N(CCc2c1c1ccccc1n2C)Cc1nc[nH]c1C
InChI InChI=1S/C17H18N4O/c1-11-13(19-10-18-11)9-21-8-7-15-16(17(21)22)12-5-3-4-6-14(12)20(15)2/h3-6,10H,7-9H2,1-2H3,(H,18,19)
InChI Key JSWZEAMFRNKZNL-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Alosetron is only used to manage severe diarrhoea-predominant irritable bowel syndrome in women.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Alosetron is a 5-HT3 antagonist and is thought to modulate serotonin-sensitive gastrointestinal processes.